DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Bodal Chemicals Limited — Outcome of Board Meeting

NSE 2 hrs ago·5 Aug 2026, 12:57 pm

Bodal Chemicals

Bodal Chemicals Limited has informed stock exchanges that its board has approved the financial results for the period ending June 30, 2026. This submission marks a key milestone in the company's reporting cycle, allowing the market to review its recent performance and financial health.

For investors, the release of these results is significant as it provides the latest data on the company's operational efficiency, profitability, and overall financial standing. The figures will be scrutinized to gauge the firm's trajectory and its ability to generate value for shareholders.

Investors should closely monitor the detailed results, including key performance indicators and management commentary, to understand the factors driving the company's current performance and future outlook.